. . . . . . . . . . . . . . "cat(p(MGI:Sptlc1)) -> a(CHEBI:ceramide)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Analysis showed that, compared with WT mice, Sptlc1(+/-) and Sptlc2(+/-) mice had: decreased liver SPT activity by 45% and 60% (P<0.01, respectively); decreased liver ceramide (22% and 39%, P<0.05 and P<0.01, respectively) and sphingosine levels (22% and 31%, P<0.05 and P<0.01, respectively);" . . "Selventa" . . . . "2014-07-03T14:32:51.230+02:00"^^ . . .